跳至主要内容
临床试验/NCT00692848
NCT00692848已完成不适用

The Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source

St. Justine's Hospital2 个研究点 分布在 1 个国家目标入组 384 人开始时间: 2006年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
384
试验地点
2
主要终点
Difference in prescription of antibiotics between the two groups, excluding those treated for a bacterial infection identified by the ED investigations

研究概览

简要总结

Serious bacterial infections are often difficult to detect in children with fever without source. Procalcitonin is a better blood marker of infection than White blood cell count and possibly than C-reactive protein. This could lead to a reduction in antibiotic prescription. Our objective is to evaluate the impact of Procalcitonin result on antibiotic prescription in children 1 to 36 month old with fever without source and our hypothesis is that it will lower the antibiotic prescription rate

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 36 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children 1-36 months
  • With rectal temperature >38.0 C
  • And no identified source of infection after history and physical examination

排除标准

  • acquired or congenital immunodeficiency

结局指标

主要结局

Difference in prescription of antibiotics between the two groups, excluding those treated for a bacterial infection identified by the ED investigations

次要结局

  • Difference in hospitalization rate between the two groups (excluding those hospitalized for an identified infection)
  • Procalcitonin sensitivity and specificity

研究者

发起方
St. Justine's Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验